Boston Scientific (BSX) Stock
NASDAQ · BSX
43.34
Fundamentals
Market cap
$62.81B
Price / Earnings ratio
17.2x
Price / Sales ratio
3.0x
Price / Book ratio
2.5x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for nearly 40 years, they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of health care.
SectorHealthcare
IndustryMedical Devices
Employees59,000
CEOMr. Michael F. Mahoney
IPO DateMay 18, 1992
HeadquartersMarlborough, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael F. Mahoney | Chairman, President & CEO | 1965 |
| Mr. Jonathan R. Monson | Executive VP & CFO | 1974 |
| Mr. Vance R. Brown J.D. | EVP, General Counsel & Corporate Secretary | 1970 |
| Mr. Joseph M. Fitzgerald | Executive VP & Group President of Cardiovascular | 1964 |
| Mr. Arthur Crosswell Butcher | Executive VP and Group President of MedSurg & Asia Pacific | 1971 |
| Mr. Paudie O'Connor | Executive Vice President of Global Operations | 1968 |
| Ms. Emily M. Woodworth | Senior VP, Global Controller & Chief Accounting Officer | 1978 |
| Mr. Adam Smith | General Manager of Global Sales & Marketing | — |
| Ms. Miriam O'sullivan | Senior VP & Chief Human Resources Officer | 1981 |
| Ms. Brenda Becker | Senior Vice President of Global Government Affairs | 1960 |
Fundamentals
Valuation
Market cap$62.81B
Price-to-sales ratio3.01
Price-to-book value2.53
Price-earnings ratio17.20
Return on Equity15.00%
Return on Sales0.20%
Return on Assets0.08%
PEG ratio0.61
Earnings Per Share
Earnings Per Share$2.49
Income Statement
Average volume21,444,708
EBITDA$5.50B
1 year high (52w)$105.65
1 year low (52w)$42.20
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



